Literature DB >> 18492909

Rapidly reversible myocardial edema in patients with acromegaly: assessment with ultrafast T2 mapping in a single-breath-hold MRI sequence.

Hervé Gouya1, Olivier Vignaux, Patrick Le Roux, Philippe Chanson, Jérome Bertherat, Xavier Bertagna, Paul Legmann.   

Abstract

OBJECTIVE: The purpose of this study was to use a single-breath-hold T2-mapping MRI sequence to evaluate the reversibility of myocardial edema in patients treated for acromegaly. SUBJECTS AND METHODS: Before and after treatment, 15 patients with acromegaly underwent myocardial T2 mapping with an experimental single-breath-hold black-blood fast spin-echo sequence. Myocardial T2 mapping with both a multiple-breath-hold fast spinecho sequence and the experimental sequence also was performed on 14 volunteers. T2 relaxation times were calculated with a standard linear least-squares fit applied to myocardial signal intensity. The T2 relaxation times of patients were compared with those of volunteers and correlated with levels of serum growth hormone and insulinlike growth factor 1. Left ventricular function and mass index were determined with cine MRI.
RESULTS: T2 values before treatment were higher in patients (71 +/- 12 milliseconds) than in volunteers (55.9 +/- 3.6 milliseconds) (p = 0.0003). These T2 values in patients decreased soon after treatment (57.6 +/- 6.6 milliseconds, p = 0.0007). This reduction correlates with successful reduction of levels of serum growth hormone and insulinlike growth factor 1. In volunteers, myocardial T2 values did not vary significantly between the single-breath-hold sequence and the multiple-breath-hold fast spin-echo sequence. In patients, myocardial mass and left ventricular function did not differ significantly before and after treatment.
CONCLUSION: Patients with acromegaly have increased myocardial T2 values, which decrease soon after treatment, reflecting reversible myocardial edema. T2 value is more sensitive than left ventricular mass index in the detection of early reversal of acromegalic cardiomyopathy. These results highlight the potential role of MRI in direct assessment of the tissular effects of growth hormone and insulinlike growth factor 1 and in evaluation of the efficacy of treatment.

Entities:  

Mesh:

Year:  2008        PMID: 18492909     DOI: 10.2214/AJR.07.2031

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  17 in total

1.  Fast cardiac T1 mapping in mice using a model-based compressed sensing method.

Authors:  Wen Li; Mark Griswold; Xin Yu
Journal:  Magn Reson Med       Date:  2011-12-09       Impact factor: 4.668

2.  High-resolution magnetic resonance colonography and dynamic contrast-enhanced magnetic resonance imaging in a murine model of colitis.

Authors:  Devkumar Mustafi; Xiaobing Fan; Urszula Dougherty; Marc Bissonnette; Gregory S Karczmar; Aytekin Oto; John Hart; Erica Markiewicz; Marta Zamora
Journal:  Magn Reson Med       Date:  2010-04       Impact factor: 4.668

Review 3.  Cardiovascular comorbidities in acromegaly: an update on their diagnosis and management.

Authors:  Ana M Ramos-Leví; Mónica Marazuela
Journal:  Endocrine       Date:  2017-01-02       Impact factor: 3.633

Review 4.  Expert consensus document: A consensus on the medical treatment of acromegaly.

Authors:  Andrea Giustina; Philippe Chanson; David Kleinberg; Marcello D Bronstein; David R Clemmons; Anne Klibanski; Aart J van der Lely; Christian J Strasburger; Steven W Lamberts; Ken K Y Ho; Felipe F Casanueva; Shlomo Melmed
Journal:  Nat Rev Endocrinol       Date:  2014-02-25       Impact factor: 43.330

5.  Accelerated cardiac T2 mapping using breath-hold multiecho fast spin-echo pulse sequence with k-t FOCUSS.

Authors:  Li Feng; Ricardo Otazo; Hong Jung; Jens H Jensen; Jong C Ye; Daniel K Sodickson; Daniel Kim
Journal:  Magn Reson Med       Date:  2011-02-28       Impact factor: 4.668

6.  Low frequency of cardniac arrhythmias and lack of structural heart disease in medically-naïve acromegaly patients: a prospective study at baseline and after 1 year of somatostatin analogs treatment.

Authors:  Leila Warszawski; Leandro Kasuki; Rodrigo Sá; Cintia Marques Dos Santos Silva; Isabela Volschan; Ilan Gottlieb; Roberto Coury Pedrosa; Mônica R Gadelha
Journal:  Pituitary       Date:  2016-12       Impact factor: 4.107

7.  Cardiac effects of 3 months treatment of acromegaly evaluated by magnetic resonance imaging and B-type natriuretic peptides.

Authors:  Mikkel Andreassen; Jens Faber; Andreas Kjær; Claus Leth Petersen; Lars Østergaard Kristensen
Journal:  Pituitary       Date:  2010-12       Impact factor: 4.107

8.  Quantitative T 2* assessment of acute and chronic myocardial ischemia/reperfusion injury in mice.

Authors:  Eissa N E Aguor; Fatih Arslan; Cees W A van de Kolk; Marcel G J Nederhoff; Pieter A Doevendans; Cees J A van Echteld; Gerard Pasterkamp; Gustav J Strijkers
Journal:  MAGMA       Date:  2012-02-11       Impact factor: 2.310

9.  Breathhold multiecho fast spin-echo pulse sequence for accurate R2 measurement in the heart and liver.

Authors:  Daniel Kim; Jens H Jensen; Ed X Wu; Sujit S Sheth; Gary M Brittenham
Journal:  Magn Reson Med       Date:  2009-08       Impact factor: 4.668

10.  Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling.

Authors:  Edythe B Tham; Mark J Haykowsky; Kelvin Chow; Maria Spavor; Sachie Kaneko; Nee S Khoo; Joseph J Pagano; Andrew S Mackie; Richard B Thompson
Journal:  J Cardiovasc Magn Reson       Date:  2013-06-10       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.